Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0178874 (
tumor progression
)
40,807
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background
. The association between human endogenous retroviruses-K (HERV-K) (
HML
-2) and human disease, including a variety of cancers, has been indicated. However, the function of HERV-K (
HML
-2) in the progression of hepatocellular carcinoma (HCC) still remains largely unclear.
Methods
. We detected the expression of HERV-K (
HML
-2) in 84 HCC tissues and adjacent nontumor tissues by quantitative real-time PCR (qRT-PCR) and analyzed its correlation with the clinical parameters.
Result
. The HEVR-K level was significantly increased in HCC compared with adjacent normal tissues (
P
< 0.01) which was proved to be significantly associated with cirrhosis (
P
< 0.05), tumor differentiation (
P
< 0.05), and TNM stage (
P
< 0.05). Moreover, the high expression of HERV-K (
HML
-2) had a poorer overall survival than patients with lower expression by a Kaplan-Meier survival analysis (
P
< 0.01). The multivariate Cox regression analysis indicated that the level of HERV-K (
HML
-2) was an independent prognostic factor for the overall survival rate of HCC patients. Receiver operating characteristic (ROC) curves demonstrated the diagnostic accuracy of HERV-K (
HML
-2) expression in HCC (AUC = 0.729, 74.7% sensitivity, and 67.8% specificity).
Conclusions
. Our results suggested that upregulation of HERV-K (
HML
-2) in HCC patients was significantly related to
cancer progression
and poor outcome, indicating that HERV-K (
HML
-2) might be a novel candidate prognostic biomarker for HCC.
...
PMID:Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma. 2807 May 18
Colon cancer is the fourth most common malignancy in both incidence and mortality in developed countries. Infectious agents are among the risk factors for colon cancer. Variations in human endogenous retrovirus (HERV) transcript and protein levels are associated with several types of cancers, but few studies address HERV expression in colon cancer. Fifty-eight patients with advanced-stage colon cancer were enrolled in this study. HERV-H, -K (
HML
-2), -P LTRs, Alu, and LINE-1 methylation levels and transcription of HERV-H, -K (
HML
-2), and -P
env
and HERV-K
pol
genes in normal adjacent and tumor tissues were investigated by pyrosequencing and RT-qPCR, respectively. Expression of the HERV-K (
HML
-2) Pol and Env proteins in selected tissues was examined by Western blotting. Associations between HERV transcript expression and methylation levels and between clinical characteristics and HERV expression were evaluated. Compared to adjacent normal tissues, LINE-1 was hypomethylated in tumor tissues (
p
< 0.05), whereas Alu, HERV-K (
HML
-2), and -H LTRs showed a decreasing trend in tumor tissue compared to normal tissue, though without a significant difference. The transcription levels of HERV
env
and
pol
genes were similar. However, the HERV-K (
HML
-2) Pol protein was more highly expressed (
p
< 0.01) in surrounding normal tissues, but the HERV-K (
HML
-2) Env protein was only expressed in tumor tissues. Although HERV LTR methylation and gene expression did not show significant differences between tumor and normal tissues, HERV protein expression differed greatly. Pol protein expression in normal cells may induce reverse transcription and subsequent integration into the host genome, likely favoring cell transformation; in contrast, the Env protein in tumor tissue may contribute to
cancer progression
through cell-to-cell fusion.
...
PMID:Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer. 3319 57